Related Experiment Video
Updated: Feb 19, 2026
07:45
Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis
Published on: January 26, 2024
2.9K
The sentinel lymph node in T1N0 breast cancer
G Paolo de Rubeis1, A Bafile, V Resta
1UO Chirurgia Oncologica, Senologia ASL 04, L'Aquila, Italy.
Tumori
|October 4, 2000
Summary
The sentinel lymph node (SN) biopsy accurately identifies breast cancer spread in most cases. However, further validation is needed before fully replacing axillary dissection in treatment.
Area of Science:
- Oncology
- Surgical Pathology
Background:
- Sentinel lymph node (SN) biopsy is a minimally invasive technique for staging breast cancer.
- Accurate staging is crucial for determining appropriate treatment and prognosis.
Purpose of the Study:
- To evaluate the feasibility and accuracy of the sentinel lymph node (SN) biopsy method in breast cancer treatment.
- To assess the diagnostic performance of SN identification and histological examination.
Main Methods:
- Prospective study of 21 breast cancer patients from December 1998 to December 1999.
- SN localization using scintigraphy and intraoperative detection.
- Histological examination of identified SN and axillary lymph nodes.
Main Results:
- Successful SN localization in 95% of cases via scintigraphy.
- Intraoperative SN identification in 90.5% of cases.
- High accuracy (95%) in detecting axillary lymph node metastasis via SN biopsy, with one false negative.
Conclusions:
- Sentinel lymph node biopsy demonstrates high accuracy in staging breast cancer.
- Despite promising results, complete axillary dissection was performed due to ongoing validation of the SN method.
- Further research is warranted to fully establish the SN method's role in breast cancer management.
